Journal List > Korean J Lab Med > v.27(4) > 1011404

Kim, Kim, Park, Song, Kang, and Lee: Distribution of TT Virus Genotypes and Genogroups in 69 Healthy and 59 Hepatitis B Virus Infected Korean Individuals

Abstract

Background

TT virus (TTV) infection is highly prevalent in general population and patients with hepatitis B virus (HBV) infection. The aim of the present study was to determine the distribution of the genotypes and genogroups of TTV in healthy and HBV-infected individuals in Korea.

Methods

Distribution of TTV genotypes and genogroups was investigated in the serum samples of 69 healthy and 59 HBV-infected individuals. PCR products of N22 region were genotyped by sequence analysis. TTV genogroups were determined by 5 different genogroup-specific PCR assays.

Results

Among the 20 sequenced isolates, 9 (45%) were genotype 2, 8 (40%) were genotype 1, 2 (10%) were genotype 3, and 1 (5%) was genotype 4. TTV genogroup 4 was found most frequently (52/128), followed by genogroup 3 (42/128), genogroup 1 (35/128), genogroup 5 (32/128), and genogroup 2 (1/128). Mixed infections with different genogroups were frequent.

Conclusions

TTV genotype 2 and 1 are predominant genotypes. TTV genotype 3 was detected for the first time in Korea. TTV genogroups 4 and 3 were predominant genogroups. No significant difference was observed in the distribution of TTV genogroups between healthy and HBV-infected individuals.

References

1. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 1997; 241:92–7.
crossref
2. Hino S. TTV, a new human virus with single stranded circular DNA genome. Rev Med Virol. 2002; 12:151–8.
crossref
3. Springfeld C, Bugert JJ, Schnitzler P, Tobiasch E, Kehm R, Darai G. TT virus as a human pathogen: significance and problems. Virus Genes. 2000; 20:35–45.
4. Leary TP, Erker JC, Chalmers ML, Desai SM, Mushahwar IK. Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. J Gen Virol. 1999; 80:2115–20.
crossref
5. Biagini P, Gallian P, Attoui H, Cantaloube JF, Touinssi M, de Micco P, et al. Comparison of systems performance for TT virus detection using PCR primer sets located in non-coding and coding regions of the viral genome. J Clin Virol. 2001; 22:91–9.
crossref
6. Kim HS, Kim JS, Song W, Kang HJ, Lee KM. TT virus detection using different PCR primer sets in healthy and infected individuals with hepatitis B or C viruses. Korean J Clin Microbiol. 2007; 10:14–8.
7. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res. 1998; 10:1–16.
crossref
8. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, et al. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. 1998; 28:839–42.
crossref
9. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol Res. 1998; 12:233–9.
crossref
10. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet. 1998; 352:191–5.
11. Huang LY, Oystein Jonassen T, Hungnes O, Grinde B. High prevalence of TT virus-related DNA (90%) and diverse viral genotypes in Norwegian blood donors. J Med Virol. 2001; 64:381–6.
crossref
12. Das K, Kar P, Gupta RK, Das BC. Role of transfusion-transmitted virus in acute viral hepatitis and fulminant hepatic failure of unknown etiology. J Gastroenterol Hepatol. 2004; 19:406–12.
crossref
13. Nakano T, Park YM, Mizokami M, Choi JY, Orito E, Ohno T, et al. TT virus infection among blood donors and patients with non-B, non-C liver diseases in Korea. J Hepatol. 1999; 30:389–93.
crossref
14. Kim EH, Cho HS, Lee CH, Kim KD. Prevalence of the TT virus viremia in patients on hemodialysis and general populations. Korean J Lab Med. 2003; 23:113–8.
15. Park SH, Byun KS, Song JW, Yeon JE, Park CK, Lee CH. Transfusion-transmitted virus infection in Korean patients with acute and chronic liver disease of unknown etiology and healthy controls: influence of PCR primers on the detection of transfusion-transmitted virus. Korean J Gastroenterol. 2003; 41:119–25.
16. Chung JY, Han TH, Seong HK, Paik IK, Kim MJ. Transfusion-transmitted virus and TTV-like mini virus Infection in blood products. Korean J Lab Med. 2004; 24:250–4.
17. Peng YH, Nishizawa T, Takahashi M, Ishikawa T, Yoshikawa A, Okamoto H. Analysis of the entire genomes of thirteen TT virus variants classifiable into the fourth and fifth genetic groups, isolated from viremic infants. Arch Virol. 2002; 147:21–41.
crossref
18. Devalle S, Niel C. Distribution of TT virus genomic groups 1–5 in Brazilian blood donors, HBV carriers, and HIV-1-infected patients. J Med Virol. 2004; 72:166–73.
crossref
19. Chung JY, Seong HK, Han TH. Distribution of transfusion-transmitted virus genomic groups in blood products. Korean J Lab Med. 2005; 25:116–22.
20. Miyata H, Tsunoda H, Kazi A, Yamada A, Khan MA, Murakami J, et al. Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol. 1999; 73:3582–6.
crossref
21. Mushahwar IK, Erker JC, Muerhoff AS, Leary TP, Simons JN, Chalmers ML, et al. Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Natl Acad Sci USA. 1999; 96:3177–82.
crossref
22. Takahashi K, Iwasa Y, Hijikata M, Mishiro S. Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch Virol. 2000; 145:979–93.
crossref
23. Okamoto H, Nishizawa T, Ukita M, Takahashi M, Fukuda M, Iizuka H, et al. The entire nucleotide sequence of a TT virus isolate from the United States (TUS01): comparison with reported isolates and phylogenetic analysis. Virology. 1999; 259:437–48.
crossref
24. Khudyakov YE, Cong ME, Nichols B, Reed D, Dou XG, Viazov SO, et al. Sequence heterogeneity of TT virus and closely related viruses. J Virol. 2000; 74:2990–3000.
crossref
25. Al-Moslih MI, Abuodeh RO, Hu YW. Detection and genotyping of TT virus in healthy and subjects with HBV or HCV in different populations in the United Arab Emirates. J Med Virol. 2004; 72:502–8.
crossref
26. Desai MM, Pal RB, Banker DD. Molecular epidemiology and clinical implications of TT virus (TTV) infection in Indian subjects. J Clin Gastroenterol. 2005; 39:422–9.
crossref
27. Gallian P, Biagini P, Zhong S, Touinssi M, Yeo W, Cantaloube JF, et al. TT virus: a study of molecular epidemiology and transmission of genotypes 1, 2 and 3. J Clin Virol. 2000; 17:43–9.
crossref
28. Katsoulidou A, Paraskevis D, Anastassopoulou CG, Chryssou SE, Sypsa V, Boletis J, et al. Prevalence and genotypic distribution of TT virus in Athens, Greece. J Med Virol. 2001; 65:423–9.
crossref
29. Tanaka Y, Mizokami M, Orito E, Ohno T, Nakano T, Kato T, et al. New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett. 1998; 437:201–6.
30. Okamoto H, Takahashi M, Nishizawa T, Ukita M, Fukuda M, Tsuda F, et al. Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology. 1999; 259:428–36.
crossref
31. Worobey M. Extensive homologous recombination among widely divergent TT viruses. J Virol. 2000; 74:7666–70.
crossref
32. Itoh K, Takahashi M, Ukita M, Nishizawa T, Okamoto H. Influence of primers on the detection of TT virus DNA by polymerase chain reaction. J Infect Dis. 1999; 180:1750–1.
crossref
33. Maggi F, Andreoli E, Lanini L, Fornai C, Vatteroni M, Pistello M, et al. Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried. J Clin Microbiol. 2005; 43:4807–10.
crossref
34. Maggi F, Pifferi M, Fornai C, Andreoli E, Tempestini E, Vatteroni M, et al. TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol. 2003; 77:2418–25.
crossref

Fig. 1.
Phylogenetic tree generated by the neighbor-joining method of the nucleotide sequence of the N22 region (nt 1939–2142) of TTV isolates from 15 healthy and 5 HBV-infected individuals. H, healthy individuals; B, HBV-infected individuals; G1a, genotype 1a; G1b, genotype 1b; G2a, genotype 2a; G2b, genotype 2b; G2c, genotype 2c; G2d, genotype 2d; G3, genotype 3; G4, genotype 4; G5, genotype 5; AB008394, AB016942, AB017769, AB017879, AB017770, AB017771, AB016936, AB016952, AB018960, AB-017774, AB017775, AB017887, and AB017776 are the GenBank database-derived isolates.
kjlm-27-257f1.tif
Fig. 2.
Deduced amino acid sequences of TTV genotype 1 (A) and TTV genotype 2 (B). Amino acid sequences are deduced from the nucleotide sequences of the N22 region (nt 1939–2142). Below the sequences, well-conserved and identical amino acid positions are indicated by colon and asterisk symbols, respectively. H, healthy individuals; B, HBV-infected individuals; AB008394, AB016942, AB017769, AB017879, AB017770, AB017771, AB-016952 and AB016936 are the GenBank database-derived isolates.
kjlm-27-257f2.tif
Table 1.
Demographic data of healthy and HBV-infected individuals
  N of cases Sex (M/F) Age (yr) mean±SD
Healthy individuals 69 50/19 43.3±12.0
HBV carriers 30 23/7 44.8±9.4
HBV liver disease 29 22/7 39.3±9.9
Total 128 95/33 42.7±10.9

Abbreviation: HBV, hepatitis B virus.

Table 2.
Oligonucleotide primers used for N22 region PCR
Primer Sequence (5′-3′)* Position Product size
Sense (1st) WCAGACAGAGGMGAAGGMAAYATG 1900–1923  
Sense (2nd) GGMAAYATGYTRTGGATAGACTGG 1915–1938  
Antisense (1st, 2nd) CTGGCATYTTWCCRTTTCCAAART 2162–2185 271 bp

* W=A or T; M=A or C; Y=C or T; R=A or G.

Table 3.
Oligonucleotide primers used for TTV genogroup-specific PCR
Primer Sequence (5′-3′)* Position Product size
1st PCR      
Sense CCGDAGGTGAGYTTACACACCG 180–201  
Antisense AGGCCYTATGGCGAAGTCTGG 3372–3352  
2nd PCR      
Sense AGTCAAGGGGCAATTCGGGC 203–222  
Antisense      
Group 1 CCATAGGCCATGGTGCTCKATC 599–578 397 bp
Group 2 GTGGTRCCCGTTCCACAGAT 897–878 700 bp
Group 3 CCTGTATCTGGCCAGGTCTAG 1083–1063 885 bp
Group 4 CGGCGGTCTCCACGGCAT 319–302 111 bp
Group 5 TCYGCGAAGTCKGCCACGGGT 678–658 485 bp

* D=A, G or T; Y=C or T; K=G or T; R=A or G.

Table 4.
Distribution of TTV genogroups in healthy and HBV-infected individuals
Genogroups N positive/N tested (%)
Healthy individuals HBV-infected individuals Total
1 20/69 (29) 15/59 (25) 35/128 (27)
2 1/69 (1) 0/59 (0) 1/128 (1)
3 26/69 (38) 16/59 (27) 42/128 (33)
4 26/69 (38) 26/59 (44) 52/128 (41)
5 15/69 (22) 17/59 (29) 32/128 (25)
Total 38/69 (55) 33/59 (56) 71/128 (56)
Table 5.
Coinfected TTV genogroups in healthy and HBV-infected individuals
N of genogroup detected N (%) of subjects
Healthy individuals (N=69) HBV-infected individuals (N=59) Total (N=128)
0 31 (45) 26 (44) 57 (45)
1 10 (14) 9 (15) 19 (15)
2 10 (14) 11 (19) 21 (16)
3 14 (20) 10 (17) 24 (19)
4 4 (6) 3 (5) 7 (5)
TOOLS
Similar articles